Day: August 13, 2019

Virpax(R) Pharmaceuticals Announces the Proposed Development of A Long Acting Naloxone and Naltrexone Liposomal Delivery To Reverse Opioid Related Respiratory Depression

Virpax Licenses Technology from Yissum Research Development Company of the Hebrew University of Jerusalem MALVERN, PA / ACCESSWIRE / August...

Imara Expands Management Team and Strengthens Expertise Across Strategic Functions as it Advances IMR-687 for Sickle Cell Disease and Beta Thalassemia

Company has appointed VPs of Program Management, Clinical Development, Technical Operations, Quality Assurance and Development Operations CAMBRIDGE, Mass.--(BUSINESS WIRE)--Imara Inc.,...

error: Content is protected !!